Merck and Moderna’s personalized mRNA cancer vaccine helps prevent melanoma recurrence and spread, raising hopes for use against other cancers.
FILE PHOTO: Merck and Moderna said their personalized mRNA cancer vaccine helped prevent melanoma from returning or spreading in a large late-stage trial, raising hopes the approach could eventually work against other cancers.
| Photo Credit:
Dado Ruvic
Merck and Moderna's
success with a personalized cancer vaccine designed to
What is Moderna’s new cancer vaccine and how big a breakthrough is it?
‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say
New Cancer Treatment Hope After mRNA Vaccine Success
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring | Fortune
Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News
New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncology
First personalized mRNA cancer vaccine succeeds in Phase 3 trial
Cancer vaccine approach may change how the disease is treated more broadly, experts say
Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a…
The companies — and others — are testing similar approaches against lung, breast and pancreatic cancers.
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and…
The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.
Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients.…
